These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 18628278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Blake JA.
    N Engl J Med; 2008 Jul 31; 359(5):531; author reply 532-3. PubMed ID: 18677798
    [No Abstract] [Full Text] [Related]

  • 3. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E, ENHANCE Investigators.
    N Engl J Med; 2008 Apr 03; 358(14):1431-43. PubMed ID: 18376000
    [Abstract] [Full Text] [Related]

  • 4. Making sense of ENHANCE: ezetimibe (Zetia) lowers LDL cholesterol but doesn't decrease carotid intima-media thickness.
    Smith D.
    Mt Sinai J Med; 2008 Apr 03; 75(2):143-7. PubMed ID: 18500716
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
    Kastelein JJ, Sager PT, de Groot E, Veltri E.
    Am Heart J; 2005 Feb 03; 149(2):234-9. PubMed ID: 15846260
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Eichhorn EJ.
    N Engl J Med; 2008 Jul 31; 359(5):529-30; author reply 532. PubMed ID: 18677795
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?
    Brown BG, Taylor AJ.
    N Engl J Med; 2008 Apr 03; 358(14):1504-7. PubMed ID: 18376002
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Diamond GA, Kaul S.
    N Engl J Med; 2008 Jul 31; 359(5):530; author reply 532. PubMed ID: 18677796
    [No Abstract] [Full Text] [Related]

  • 12. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Steinberg D.
    N Engl J Med; 2008 Jul 31; 359(5):529; author reply 532. PubMed ID: 18669434
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extended-release niacin or ezetimibe and carotid intima-media thickness.
    Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M.
    N Engl J Med; 2009 Nov 26; 361(22):2113-22. PubMed ID: 19915217
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cholesterol lowering and ezetimibe.
    Drazen JM, Jarcho JA, Morrissey S, Curfman GD.
    N Engl J Med; 2008 Apr 03; 358(14):1507-8. PubMed ID: 18376001
    [No Abstract] [Full Text] [Related]

  • 17. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
    Masiá M, Bernal E, Padilla S, García N, Escribano JC, Martínez E, Gutiérrez F.
    J Antimicrob Chemother; 2009 Sep 03; 64(3):589-98. PubMed ID: 19625372
    [Abstract] [Full Text] [Related]

  • 18. Subclinical atherosclerosis: evolving role of carotid intima-media thickness.
    Mookadam F, Moustafa SE, Lester SJ, Warsame T.
    Prev Cardiol; 2010 Sep 03; 13(4):186-97. PubMed ID: 20860643
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.